Strimvelis® for Treating Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency: An Evidence Review Group Perspective of a NICE Highly Specialised Technology Evaluation [0.03%]
斯特里姆维尔司（Strimvelis）治疗腺苷脱氨酶缺陷所致严重联合免疫缺陷病：NICE高端技术评价的证据审查组观点报告
Emily South,Edward Cox,Nick Meader et al.
Emily South et al.
The Centre for Reviews and Dissemination and Centre for Health Economics Technology Assessment Group at the University of York was commissioned by the National Institute for Health and Care Excellence (NICE) Highly Specialised Technologies ...
Working with Patients and Members of the Public: Informing Health Economics in Child Health Research [0.03%]
与患者及公众合作：儿童健康研究中卫生经济学的信息来源
Rebecca Kandiyali,Annie Hawton,Christie Cabral et al.
Rebecca Kandiyali et al.
This paper considers patient and public involvement (PPI) in health economics research and how this might be facilitated. PPI refers to research carried out 'with' or 'by' members of the public and is now an important aspect of health resea...
Time and Cost of Hospitalisation for Salvage Therapy in Adults with Philadelphia Chromosome-Negative B Cell Precursor Relapsed or Refractory Acute Lymphoblastic Leukaemia in Spain [0.03%]
西班牙成人Ph阴性B细胞急性淋巴细胞白血病复发病人的挽救治疗住院时间和费用分析
Blanca Boluda,Rebeca Rodríguez-Veiga,David Martínez-Cuadrón et al.
Blanca Boluda et al.
Background: Philadelphia chromosome-negative (Ph-) relapsed or refractory (R/R) B-cell precursor acute lymphoblastic leukaemia (ALL) is rare, and information on its impact on healthcare systems is scarce. ...
Economic Burden of Patients Treated for Higher-Risk Myelodysplastic Syndromes (HR-MDS) in Routine Clinical Care in the United States [0.03%]
美国临床环境中根据风险程度较高的骨髓增生异常综合症（HR-MDS）治疗患者的经济负担
Jill A Bell,Aaron Galaznik,Marlo Blazer et al.
Jill A Bell et al.
Background and objective: Significant clinical burden is associated with higher-risk myelodysplastic syndromes (HR-MDS); however, the economic burden has not been fully examined. We examined cost of care and healthcare ut...
Evaluating the Outcomes Associated with Genomic Sequencing: A Roadmap for Future Research [0.03%]
解读基因组测序结果对健康的影响：未来研究路线图
James Buchanan,Sarah Wordsworth
James Buchanan
Correction to: Cost-Effectiveness Analysis of Single-Use EEG Cup Electrodes Compared with Reusable EEG Cup Electrodes [0.03%]
Correction to: 一次性EEG杯状电极与可重复使用EEG杯状电极的成本效益分析
Anne Sohrt,Anders Mærkedahl,William V Padula
Anne Sohrt
In the Results section of the abstract, the second sentence which previously read.
Published Erratum
PharmacoEconomics - open. 2019 Jun;3(2):273. DOI:10.1007/s41669-018-0095-y 2019
Does Structured Exercise Improve Cognitive Impairment in People with Mild to Moderate Dementia? A Cost-Effectiveness Analysis from a Confirmatory Randomised Controlled Trial: The Dementia and Physical Activity (DAPA) Trial [0.03%]
运动干预改善轻至中度痴呆患者认知功能的成本效益分析：DAPA试验
Iftekhar Khan,Stavros Petrou,Kamran Khan et al.
Iftekhar Khan et al.
Background: Previous studies suggest that physical exercise could slow dementia progression. However, evidence for the cost effectiveness of structured exercise is conflicting and based on small trials. ...
Correction to: Can We Accurately Predict Cost Effectiveness Without Access to Overall Survival Data? The Case Study of Nivolumab in Combination with Ipilimumab for the Treatment of Patients with Advanced Melanoma in England [0.03%]
对“没有总生存数据我们能否准确预测成本效益？伊匹木单抗联合尼伏鲁马布治疗英国晚期黑色素瘤患者的案例研究”的更正
D Lee,A Amadi,J Sabater et al.
D Lee et al.
The second Key Point for Decision Makers, which reads.
Published Erratum
PharmacoEconomics - open. 2019 Mar;3(1):127. DOI:10.1007/s41669-018-0096-x 2019
Value Assessment Frameworks in the United States: A Call for Patient Engagement [0.03%]
美国的价值评估框架：患者参与的呼吁
Vakaramoko Diaby,Askal A Ali,Alberto J Montero
Vakaramoko Diaby
High Healthcare Resource Use in Hospitalized Patients with a Diagnosis of Spinal Muscular Atrophy Type 1 (SMA1): Retrospective Analysis of the Kids' Inpatient Database (KID) [0.03%]
美国儿童住院数据库(SPID)中脊髓性肌萎缩症Ⅰ型(SMA1)患儿的医疗资源利用分析
Jessica Cardenas,Melissa Menier,Marjet D Heitzer et al.
Jessica Cardenas et al.
Background: Patients with spinal muscular atrophy (SMA) have high healthcare resource use (HRU) due to respiratory and nutritional complications resulting from progressive muscle atrophy. While previous studies estimate t...